An interventional study of Double Baloon Catheter and Membrane Stripping in Labor, Induced, Cervical Ripening and Balloon Induction, sponsored by Meir Medical Center. Recruiting at 1 site in Israel. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-15.
Sponsored by Meir Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction.
The study population consists of women undergoing labor induction.
The main questions it aims to answer are:
Meir Medical Center is the lead sponsor of 402 studies on the registry; 26 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A Double balloon catheter will be inserted for 12 hours in this group of women
Device: Double Baloon Catheter
This group of women will undergo membrane stripping twice (every 4-6 hours) over a period of 12 hours
Procedure: Membrane Stripping
This group of women will undergo cervical ripening using a vaginal PGE2 pessary
Drug: PGE2
A double Baloon Catheter will be inserted for 12 hours to one of the arms of the study
Stripping will be considered as 3-5 rotations of separating the amniotic sac from the cervix and will be perfomed twice (every 4-6 hours)
A PGE2 vaginal pessary (Cervidil) will be inserted for 12-24 hours
Rates of successful cervical ripening at the end of 12 hours, duration of cervical ripening
What percentage of the women in this arm had a successful cervical ripening after 12 hours
Time frame: from 12 hours after intervention until patient&s discharge or 150 hours, whichever came first, assessed up to 100 months
Rates of vaginal delivery within 24 hours
What percentage of the women in this arm delivered within 24 hours
Time frame: from 12 hours after intervention until patients discharge or 150 hours, whichever came first, assessed up to 100 months
Started Aug 2024 (actual). Primary completion is estimated for Dec 2027, 40 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dinoprostone